Optimised surveillance of minor to moderate bronchial dysplasia in a risky population: more precision strategies needed

Xiao Fei Wang^{1

2}, Qing Yun Li^{3

2}

Affiliations

¹ Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
² Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
³ Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China liqingyun68@hotmail.com.

Comment

Xiao Fei Wang et al. Eur Respir J. 2023.

. 2023 Jan 27;61(1):2202264.

doi: 10.1183/13993003.02264-2022. Print 2023 Jan.

Xiao Fei Wang^{1

2}, Qing Yun Li^{3

2}

¹ Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
² Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
³ Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China liqingyun68@hotmail.com.

No abstract available

Conflict of interest statement

Conflict of interest: The authors declare no competing interests.

Endoscopic follow-up of low-grade precancerous bronchial lesions in high-risk patients: long-term results of the SELEPREBB randomised multicentre trial.
Guisier F, Deslee G, Birembaut P, Escarguel B, Chapel F, Bota S, Métayer J, Lachkar S, Capron F, Homasson JP, Taulelle M, Quintana M, Raspaud C, Messelet D, Benzaquen J, Hofman P, Baddredine J, Paris C, Cales V, Laurent P, Vignaud JM, Ménard O, Copin MC, Ramon P, Bouchindhomme B, Tavernier JY, Quintin I, Quiot JJ, Galateau-Sallé F, Zalcman G, Piton N, Thiberville L. Guisier F, et al. Eur Respir J. 2022 Sep 15;60(3):2101946. doi: 10.1183/13993003.01946-2021. Print 2022 Sep. Eur Respir J. 2022. PMID: 35236723 Clinical Trial.